IP Library Granted Patent US 10,646,450
Granted Patent B2
US 10,646,450 · App. 16/045,287 · Granted May 12, 2020

Delivery system comprising a core and a digestible polymer shell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,646,450
App. No.
16/045,287
Granted
May 12, 2020
Kind
B2
Abstract

A delivery vehicle with a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of an animal or human, and where the core has a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix. The delivery vehicle can be used to release lipid and/or lipophilic active ingredients, such as pharmaceuticals, nutraceuticals, supplements, traditional/herbal medicine, or combinations thereof, after a predetermined lag time following ingestion.

Claims (38)

1. A delivery vehicle comprising a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of an animal or human, wherein the core comprises a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix, and wherein the digestible polymer comprised within the digestible polymer shell is a cross linked digestible biopolymer.

2. The delivery vehicle according to claim 1 , wherein the polymer matrix is solid below the body temperature of an animal or human and a solid or a liquid at or above the body temperature of an animal or human.

3. The delivery vehicle according to claim 1 , wherein the polymer matrix is a biopolymer matrix and wherein the biopolymer is selected from the group consisting of: gelatine, carrageenans, pectin, alginates, agar, gellan, konjac mannan, guar gum, gellan gum, locust bean gum, and combinations thereof.

4. The delivery vehicle according to claim 1 , wherein the lipid and/or lipophilic active ingredient is selected from the group consisting of: a pharmaceutical, nutraceutical, supplement, veterinary drug, natural/traditional medicine, food ingredient, and combinations thereof.

5. A delivery vehicle comprising a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of an animal or human,

wherein the core comprises a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix,

wherein the digestible polymer comprised within the digestible polymer shell is a cross linked digestible biopolymer, and

wherein the lipid and/or lipophilic active ingredient is selected from the group consisting of: triglycerides, phospholipids, diglycerides, monoglycerides, ceramides, glycolipids and sphingolipids, fish oil, petroselinic acid, eicosapentaenoic acid, carotenoids, phytosterols, phytosterol esters, polyphenols, cholesterol, cholesterol esters, retinol, retinol ester, and combinations thereof.

6. A delivery vehicle comprising a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of an animal or human,

wherein the core comprises a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix,

wherein the digestible polymer comprised within the digestible polymer shell is a cross linked digestible biopolymer, and

wherein the core contains an emulsifier.

7. The delivery vehicle according to claim 1 , wherein the digestible polymer shell is formed from one or more biopolymer selected from the group consisting of: Bovine serum albumin, β-lactoglobulin, lactoferrin, whey protein isolate patatin, soy protein, canola protein, pea protein, egg protein, lysozyme, pea proteins, lupin, rice protein, gluten, lysozyme, zein, and combinations thereof.

8. A delivery vehicle comprising a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of an animal or human,

wherein the core comprises a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix,

wherein the digestible polymer comprised within the digestible polymer shell is a cross linked digestible biopolymer, and

wherein the digestible polymer shell has an average mesh/pore size of <50 nm.

9. A delivery vehicle comprising a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of an animal or human,

wherein the core comprises a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix,

wherein the digestible polymer comprised within the digestible polymer shell is a cross linked digestible biopolymer, and

wherein the core comprises a weighting agent and/or wherein the digestible polymer shell comprises a thickener.

10. A delivery vehicle comprising a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of a subject,

wherein the core comprises a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix,

wherein the digestible polymer comprised within the digestible polymer shell is a cross linked digestible biopolymer, and

wherein 50% or more of the lipid and/or lipophilic active ingredient is released within 45 minutes or less and/or 80% or more of the lipid and/or lipophilic active ingredient is release within 75 minutes or less following the expiry of a predetermined lag time following ingestion of said delivery vehicle by the subject.

11. A consumable product comprising a delivery vehicle comprising a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of a subject, wherein the core comprises a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix, and wherein the digestible polymer comprised within the digestible polymer shell is a cross linked digestible biopolymer, the composition and/or consumable product is selected from the group consisting of; pharmaceutical products, nutraceutical products, medical foods, veterinary products including pet food and pet care products and, foodstuffs of any kind including functional foods and food supplements.

12. The consumable product according to claim 11 , wherein the lipid and/or lipophilic active ingredient is selected from the group consisting of: triglycerides, phospholipids, diglycerides, monoglycerides, ceramides, glycolipids and sphingolipids, fish oil, petroselinic acid, eicosapentaenoic acid, carotenoids, phytosterols, phytosterol esters, polyphenols, cholesterol, cholesterol esters, retinol, retinol ester, and combinations thereof.

13. The consumable product according to claim 11 , wherein the core contains an emulsifier.

14. The consumable product according to claim 11 , wherein the digestible polymer shell has an average mesh/pore size of <50 nm.

15. The consumable product according to claim 11 , wherein the core comprises a weighting agent and/or wherein the digestible polymer shell comprises a thickener.

16. The consumable product according to claim 11 , wherein 50% or more of the lipid and/or lipophilic active ingredient is released within 45 minutes or less and/or 80% or more of the lipid and/or lipophilic active ingredient is release within 75 minutes or less following the expiry of a predetermined lag time following ingestion of said delivery vehicle by the subject.

17. The consumable product according to claim 11 , wherein the cross linked digestible biopolymer is a thermally cross linked digestible biopolymer.

18. The delivery vehicle according to claim 1 , wherein the cross linked digestible biopolymer is a thermally cross linked digestible biopolymer.

19. The delivery vehicle according to claim 5 , wherein the cross linked digestible biopolymer is a thermally cross linked digestible biopolymer.

20. The delivery vehicle according to claim 6 , wherein the cross linked digestible biopolymer is a thermally cross linked digestible biopolymer.

21. The delivery vehicle according to claim 8 , wherein the cross linked digestible biopolymer is a thermally cross linked digestible biopolymer.

22. The delivery vehicle according to claim 9 , wherein the cross linked digestible biopolymer is a thermally cross linked digestible biopolymer.

23. The delivery vehicle according to claim 10 , wherein the cross linked digestible biopolymer is a thermally cross linked digestible biopolymer.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2019
From: WOOSTER, TIMOTHY JAMES; DONATO-CAPEL, LAURENCE; SARKAR, ANWESHA; ACOUISTAPACE, SIMONE
To: NESTEC S.A.,
Reel/Frame 049826/0458 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →